NEW YORK, May 28, 2015 /PRNewswire-USNewswire/ -- Voices Against Brain Cancer, a national non-profit organization committed to finding a cure for brain cancer and brain tumors, and the Feinstein Institute for Medical Research in Long Island, will be hosting a Brain Tumor Biotech Summit on Friday, May 29th, 2015 at Lenox Hill Hospital's Einhorn Auditorium in Manhattan. The one-day event is designed to bring together top researchers, doctors, investors, biotech companies, and more, who are exceptionally involved in neuroscience and oncology, to share information on emerging therapies for brain tumors.
With the support from industry leaders from around the world, during the summit, leading brain tumor researchers and doctors will present their latest advancements in neuroscience, all which are relevant to the treatment of brain cancer.
Key Note Speakers include:
- Robert B. Darnell MD, PhD, The Rockefeller University
- Michael Lim, MD, Johns Hopkins University
- Donald M. O'Rourke, MD, University of Pennsylvania
- Michael A. Vogelbaum, MD, PhD, FAANS, FACS, Case Western Reserve University
Special Guests include:
- Michael J. Dowling, President and CEO of North Shore-LIJ Health System
- Anthony Scaramucci, Founder and Managing Partner at SkyBridge Capital
- Kevin J. Tracey, MD, President and CEO of the Feinstein Institute for Medical Research
Each will provide insight into the future of biotech companies and the use of their drugs. Data on CAR-T Immune Biotechnology will also be presented by Donald O'Rourke, as this innovative technology has seen great success in certain types of Leukemia, and has achieved long term remissions in patients who have exhausted other treatments in their battle with cancer.
Seminars throughout the day include Immunomodulatory Therapies for Glioblastoma, New Delivery Modalities and Novel Applications and Treatment for Malignant Glioma. The complete agenda for the summit can be found here: http://www.feinsteininstitute.org/brain-tumor-biotech-center/brain-tumor-biotech-summit-2015/#top-anchor.
"With thousands of families afflicted by this devastating disease each year, our organization continues the push for awareness and research for a cure," said Mario Lichtenstein, Founder of Voices Against Brain Cancer. "By bringing together such remarkable innovators from the medical field through the Biotech Summit, we are able to learn more about the advancements and research being made each day, to ultimately find a cure for brain tumors and brain cancer."
Voices Against Brain Cancer, leaders in the brain cancer community, was founded in loving memory of Gary Lichtenstein, who lost his valiant battle with brain cancer on October 1, 2003. Since then, the organization has garnered support from other patients, survivors, their families, caregivers, prestigious doctors and celebrities, all united in their drive towards finding a cure for this devastating disease.
For press inquiries, please contact: 5W Public Relations.
About Voices Against Brain Cancer
Voices Against Brain Cancer's (VABC) mission is to find a cure for brain cancer and brain tumors by advancing scientific research, increasing awareness, creating a brain cancer and tumor community, and supporting patients, their families and caregivers afflicted with this devastating disease.
Voices Against Brain Cancer was started in loving memory of Gary Lichtenstein who at 24 years old lost his battle with brain cancer on October 1, 2003. Gary was living in Chicago and working as an options trader at Wolverine Trading when he was diagnosed with a brain tumor in March of 2003. After three months of radiation, Gary slipped into a coma from which he did not recover. Soon after his passing, Gary's family started Voices Against Brain Cancer to raise money and awareness for the fight against this devastating disease.
"I couldn't save the life of my son, but perhaps I can save the life of others."
-Mario Lichtenstein, Founder Of VABC
VABC has a wide variety of initiatives in motion for brain cancer research, awareness and support. The organization's research grants fund cutting-edge programs that will have a monumental impact on the diagnosis and treatment of brain cancer and brain tumors. Currently, these grants are being funded at numerous esteemed institutions including: Baylor University, Boston Children's Hospital / Harvard, Brain Tumor Biotech Center / Feinstein Institute / North Shore LIJ Health System, Brookhaven National Laboratory, Central Brain Tumor Registry Of The United States, Children's Hospital Of Philadelphia / University Of Pennsylvania, Cleveland Clinic, Columbia, Cornell, Dana Farber / Harvard, Duke, The Feinstein Institute / North Shore LIJ Health System, Harvard, Hofstra / North Shore LIJ School Of Medicine, Johns Hopkins, Lenox Hill Hospital / North Shore LIJ Health System, Long Island Brain Tumor Center, NY, Lurie Children's Hospital / Northwestern, Massachusetts General Hospital / Harvard, MD Anderson, Memorial Sloan Kettering, New York University, Northwestern University, Ohio State University, Rush University, Stony Brook University, University Of California Davis, University Of California Irvine, University Of California Los Angeles, University Of California San Diego, University Of California San Francisco, University Of Chicago, University Of Michigan, University Of Pittsburgh, University Of Texas San Antonio, University Of Virginia, Vanderbilt University, Wake Forest, Washington University, Yale and more.
VABC extends throughout the international community and funds research in countries such as Australia, Canada, Israel, Spain and more. As part of the Foundation's commitment to "leave no stone unturned" in the search for a cure, VABC supports Cannabis Research and the exploration of the potential risks associated with Mobile Phone Radiation.
VABC continues to hold events across the country in locations such as Atlanta, Boston, Chicago, Connecticut, Dallas, Las Vegas, Long Island-New York, Los Angeles, Miami, New Jersey, New Orleans, New York City, New York City Half Marathon, New York City Marathon, North Carolina, Oklahoma City, Phoenix, Portland, Salt Lake City, San Francisco, Seattle, Tampa, Virginia and Washington, DC.
SOURCE Voices Against Brain Cancer